VolitionRx Limited ("Volition"), a multi-national epigenetics company, today announced the results of a large-scale study which shows that its Nu.Q®NETs H3.1 biomarker is an independent predictor of ...

细菌性肺炎是一种严重的公共卫生负担，它不仅导致了大量的发病率和死亡率，还带来了沉重的医疗成本。尽管抗生素和辅助治疗是目前的主要治疗手段，但对于疾病发病机制的深入理解仍然有限。